SD

Sangita Devi

Active Director Director DIN 09507094
DIN 09507094 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Sangita Devi

Data last updated:

Sangita Devi is a Director at Klarzen Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Klarzen Pharmaceuticals Private Limited reported revenue of ₹4.5 Lakh (FY 2025).

DIN 09507094
Primary Designation Director
Industry Chemicals
First Appointment 15 Feb 2022
Oldest Company Age 7 yrs
Largest company Klarzen Pharmaceuticals Private Limited · ₹4.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Feb 20222019₹4.5 Lakh (FY 2025)Active

Board colleagues of Sangita Devi

NameDINCompanyDesignation
Rajendra Bhagat08590692Klarzen Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Klarzen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sangita Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangita Devi

Sangita Devi currently holds 1 directorship: Klarzen Pharmaceuticals Private Limited (Director, since 15 Feb 2022, revenue ₹4.5 Lakh (FY 2025)).

Sangita Devi was first appointed on 15 Feb 2022 as Director at Klarzen Pharmaceuticals Private Limited.

The current boards of Sangita Devi's companies include Rajendra Bhagat (Klarzen Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available